Table 2. Antimicrobial activity of developed formulations against E. coli biofilm .
Formulations | Mean % Inhibition at 0.25X MIC | Mean % Inhibition at 0.5X MIC | Mean % Inhibition at 01X MIC | Mean % Inhibition at 2X MIC | |
NE I | P60+Cran NE | 73.97 | 78.37* | 82.46 | 92.62 |
Placebo | 59.26 | 69.64 | 91.04 | 94.03 | |
Aqueous Solution | 37.37 | 60.78 | 80.88 | 82.95 | |
NE II | P60+Cur NE | 56.82 | 76.50* | 96.36* | 97.28* |
Placebo | 46.34 | 68.80 | 85.69 | 97.03 | |
Aqueous solution | 43.36 | 48.51 | 50.13 | 59.62 |
Where MIC is the minimum inhibitory concentration; P60 is polyphenon 60; Cran is cranberry; Cur is curcumin; NE is nanoemulsion. * indicated high antibacterial activity of NEs as compared to the aqueous drug solutions. (1x concentration for P60 was 3.3 mg/mL and for Cran was 10 mg/mL and for Cur was 0.3 mg/mL).